<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04888104</url>
  </required_header>
  <id_info>
    <org_study_id>2139</org_study_id>
    <nct_id>NCT04888104</nct_id>
  </id_info>
  <brief_title>Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients</brief_title>
  <official_title>Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Spine Study Group Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NuVasive</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>International Spine Study Group Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to&#xD;
      Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult&#xD;
      Patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aims:&#xD;
&#xD;
        -  Evaluate the safety and performance of posterior spinal fusion constructs supplemented&#xD;
           with posterior spinolaminar fixation using the VersaTie System compared to posterior&#xD;
           fixation constructs without VersaTie System supplementation in adult patients undergoing&#xD;
           long posterior spinal fusion by evaluating intraoperative and postoperative&#xD;
           complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and&#xD;
           need for revision surgery.&#xD;
&#xD;
        -  Evaluate surgical treatment outcomes and identify best practice guidelines for complex&#xD;
           adult spinal deformity (ASD) patients, including radiographic and clinical outcomes,&#xD;
           surgical and postoperative complications, risk factors for and revision surgery.&#xD;
&#xD;
        -  Develop and validate a standardized, universal complications classification system for&#xD;
           spine surgery&#xD;
&#xD;
        -  Evaluate perioperative blood management approaches, transfusion requirements, including&#xD;
           variance in thresholds for blood transfusion and associated complications for adult&#xD;
           spinal deformity surgery&#xD;
&#xD;
        -  Assess impact of opioid use and pain management on patient cost, complications and&#xD;
           outcomes&#xD;
&#xD;
        -  Evaluate optimal opioid and analgesic usage and protocols for standard work development&#xD;
&#xD;
        -  Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs)&#xD;
           including modified Oswestry Disability Index (mODI), Scoliosis Research Society&#xD;
           Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale&#xD;
           (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by&#xD;
           the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS&#xD;
           Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction.&#xD;
           Secondary aims for PROM research for this study include&#xD;
&#xD;
             1. Validation of the PROMIS tool for ASD&#xD;
&#xD;
             2. Establish a core set of PROMs for best practice guidelines for ASD&#xD;
&#xD;
             3. Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine&#xD;
                deformity type including variance in baseline PROM domains impacted and variance in&#xD;
                improvement in PROM domains&#xD;
&#xD;
             4. Evaluate ASD outcomes compared to population norms and investigate/develop&#xD;
                appropriate measures of clinically significant improvement&#xD;
&#xD;
        -  Evaluate clinical outcomes stratifying by patient chronological and physiological age&#xD;
&#xD;
        -  Evaluate measures to quantify patient physiological age including patient frailty for&#xD;
           ASD and validate a frailty measurement system for ASD&#xD;
&#xD;
        -  Evaluate the role of functional tests in patient's baseline frailty assessment including&#xD;
           hand manometer and Edmonton Frail Scale. See appendix, pages 17 &amp; 18 for details.&#xD;
&#xD;
        -  Evaluate the contribution of patient frailty to patient outcomes, complications, cost of&#xD;
           care, disability, and complications&#xD;
&#xD;
        -  Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that&#xD;
           can be improved through &quot;pre-habilitation&quot; and if the according associations with&#xD;
           reductions in frailty correlate with reductions of cost, complications, and improvement&#xD;
           in outcomes&#xD;
&#xD;
        -  Evaluate cost variance for ASD surgery according to patient, institution, and&#xD;
           geographical region and evaluate the cost effectiveness of surgical intervention for ASD&#xD;
&#xD;
        -  Evaluate incidence of and risk factors for mental health (MH) compromise among ASD&#xD;
           patients and establish best practice guidelines for assessing MH for ASD patients&#xD;
&#xD;
        -  Evaluate the association of MH with surgical complications, outcomes, hospital length of&#xD;
           stay and cost for ASD surgery&#xD;
&#xD;
        -  Evaluate the association of social health surgical complications, outcomes, hospital&#xD;
           length of stay and cost for ASD surgery and risk factors for routine (home) discharge&#xD;
           vs. skilled nursing facility (SNF)/rehabilitation facility&#xD;
&#xD;
        -  Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of&#xD;
           the entirety of the episode of care to include steps that can be taken prior to surgery&#xD;
           including &quot;prehabilitation,&quot; pain management, and MH care to improve treatment outcomes,&#xD;
           reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce&#xD;
           early and late complications&#xD;
&#xD;
        -  Establish a core set of standard work guidelines to clinically and radiographically&#xD;
           evaluate and treat ASD patients and evaluate the utility of standard work to improve&#xD;
           outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD&#xD;
&#xD;
        -  Develop predictive analytic algorithms to risk stratify for best/worst outcomes,&#xD;
           complications, sentinel events, and economic loss for ASD surgery&#xD;
&#xD;
        -  Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult&#xD;
           spinal deformity surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2034</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2034</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Scoliosis Research Society (SRS) 22r</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Scoliosis specific patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Spine specific patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Veterans RAND 12 Item Health Survey (VR-12)</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) - Depression</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale - Back Pain</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale - Leg Pain</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Edmonton Frail Scale</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Evaluate frailty on scale of 0 to 17 where higher scores mean more frail</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Canadian Study of Health and Aging (CSHA)</measure>
    <time_frame>Change from Preop to 3 months and 1, 2, 5 &amp; 10 year follow-up</time_frame>
    <description>Frailty scale of 1 to 9; higher scores mean more frail</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>3 months and 1, 2, 5 &amp; 10 year post treatment</time_frame>
    <description>Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study&#xD;
[Time Frame: 3 months and 1, 2, 5 &amp; 10 year post treatment]</description>
  </secondary_outcome>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Adult Spinal Deformity</condition>
  <condition>Scoliosis</condition>
  <condition>Kyphosis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Index or revision spine surgery for complex adult spinal deformity</intervention_name>
    <description>Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.</description>
    <other_name>VersaTie System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Multicenter, prospective, observational, study evaluating the safety and performance of the&#xD;
        VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal&#xD;
        fusion with pedicle screw fixation supplemented at the proximal aspect of the construct&#xD;
        with the VersaTie System&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. &gt;18 years of age at the time of treatment&#xD;
&#xD;
          2. EOS full body or standing 36&quot; AP &amp; Lateral images of entire spine&#xD;
&#xD;
          3. Posterior spine fusion with pedicle screw fixation construct of 5 or more levels&#xD;
&#xD;
          4. Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system&#xD;
&#xD;
          5. Upper instrumented vertebra (UIV) terminating at a newly instrumented level&#xD;
&#xD;
          6. Lowest instrumented vertebra (LIV) sacrum/pelvis&#xD;
&#xD;
          7. Surgery scheduled to take place in the next 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active spine tumor or infection&#xD;
&#xD;
          2. Deformity due to acute trauma&#xD;
&#xD;
          3. Prisoners&#xD;
&#xD;
          4. Women who are pregnant&#xD;
&#xD;
          5. Patient is unwilling or unable to complete questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Shay Bess, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Presbyterian/St Luke's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey Mullin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University at Buffalo, Department of Neurosurgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Shaffrey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University Medical Center, Section of Spine Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Justin Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia Medical Center, Department of Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine Baldus, MH</last_name>
    <phone>6184444130</phone>
    <email>baldusc@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ray Pinteric</last_name>
    <phone>7209348014</phone>
    <email>ray.pinteric@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Courtney Hemphill</last_name>
      <email>courtney.hemphill@barrowneuro.org</email>
    </contact>
    <investigator>
      <last_name>Jay Turner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shiley Center for Orthopaedic Research and Education at Scripps Clinic</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Tina Iannacone, MPH</last_name>
      <phone>858-554-7124</phone>
      <email>iannacone.tina@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Gregory Mundis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Eastlack, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana Spine Institute</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Brandi Casey</last_name>
      <email>bcasey@louisianaspine.org</email>
    </contact>
    <investigator>
      <last_name>Pierce Nunley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University at Buffalo, Department of Neurosurgery</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14260-1660</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Tia Warrick</last_name>
      <email>twarrick@ubns.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Mullin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University, Department of Orthopedic Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Brooke O'Connell</last_name>
    </contact>
    <investigator>
      <last_name>Peter Passias, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Themistocles Protopsaltis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery, Department of Orthopedic Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Virginie LaFage, PhD</last_name>
      <email>virginie.lafage@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Han Jo Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Schwab, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Health System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Joshua Hoover</last_name>
      <phone>919-613-3801</phone>
      <email>joshua.hoover@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher I Shaffrey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Lorrie Sipe</last_name>
      <phone>434-924-8875</phone>
      <email>lag3k@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Justin Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2021</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Scoliosis</keyword>
  <keyword>Kyphosis</keyword>
  <keyword>Sagittal Imbalance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
    <mesh_term>Kyphosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

